{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,7]],"date-time":"2026-10-07T19:10:57Z","timestamp":1791400257706,"version":"4.3.3"},"reference-count":37,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2018,10,1]],"date-time":"2018-10-01T00:00:00Z","timestamp":1538352000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2018,10,1]],"date-time":"2018-10-01T00:00:00Z","timestamp":1538352000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["21474104"],"award-info":[{"award-number":["21474104"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["51520105004"],"award-info":[{"award-number":["51520105004"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["51390484"],"award-info":[{"award-number":["51390484"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["51403205"],"award-info":[{"award-number":["51403205"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["51503200"],"award-info":[{"award-number":["51503200"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Jilin Province Science and Technology Development Program","award":["20160204032GX"],"award-info":[{"award-number":["20160204032GX"]}]},{"name":"Jilin Province Science and Technology Development Program","award":["20180414027GH"],"award-info":[{"award-number":["20180414027GH"]}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Acta Biomaterialia"],"published-print":{"date-parts":[[2018,10]]},"DOI":"10.1016\/j.actbio.2018.09.015","type":"journal-article","created":{"date-parts":[[2018,9,15]],"date-time":"2018-09-15T20:58:24Z","timestamp":1537045104000},"page":"144-153","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":39,"special_numbering":"C","title":["Polylysine-modified polyethylenimine polymer can generate genetically engineered mesenchymal stem cells for combinational suicidal gene therapy in glioblastoma"],"prefix":"10.1016","volume":"80","author":[{"given":"Yousra Saeed","family":"Malik","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Muhammad Abid","family":"Sheikh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhenkai","family":"Xing","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhaopei","family":"Guo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaojuan","family":"Zhu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Huayu","family":"Tian","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xuesi","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.actbio.2018.09.015_b0005","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1093\/neuonc\/1.3.205","article-title":"Centralized databases available for describing primary brain tumor incidence, survival, and treatment: Central Brain Tumor Registry of the United States; Surveillance, Epidemiology, and End Results; and National Cancer Data Base","volume":"1","author":"Davis","year":"1999","journal-title":"Neuro-oncology"},{"key":"10.1016\/j.actbio.2018.09.015_b0010","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1038\/sj.cgt.7700886","article-title":"Genetic strategies for brain tumor therapy","volume":"13","author":"Lawler","year":"2006","journal-title":"Cancer Gene Therapy"},{"key":"10.1016\/j.actbio.2018.09.015_b0015","doi-asserted-by":"crossref","first-page":"1155","DOI":"10.1038\/sj.gt.3302276","article-title":"Antitumor effect of genetically engineered mesenchymal stem cells in a rat glioma model","volume":"11","author":"Nakamura","year":"2004","journal-title":"Gene Therapy"},{"key":"10.1016\/j.actbio.2018.09.015_b0020","doi-asserted-by":"crossref","first-page":"3307","DOI":"10.1158\/0008-5472.CAN-04-1874","article-title":"Human bone marrow-derived mesenchymal stem cells in the treatment of gliomas","volume":"65","author":"Nakamizo","year":"2005","journal-title":"Cancer Res."},{"key":"10.1016\/j.actbio.2018.09.015_b0025","doi-asserted-by":"crossref","first-page":"5","DOI":"10.4252\/wjsc.v2.i1.5","article-title":"The bad and the good of mesenchymal stem cells in cancer: Boosters of tumor growth and vehicles for targeted delivery of anticancer agents","volume":"2","author":"Galderisi","year":"2010","journal-title":"World J. Stem Cells"},{"key":"10.1016\/j.actbio.2018.09.015_b0030","doi-asserted-by":"crossref","first-page":"488","DOI":"10.1038\/gt.2010.170","article-title":"The effects of mesenchymal stem cells injected via different routes on modified IL-12-mediated antitumor activity","volume":"18","author":"Seo","year":"2011","journal-title":"Gene Therapy"},{"key":"10.1016\/j.actbio.2018.09.015_b0035","doi-asserted-by":"crossref","first-page":"44","DOI":"10.2174\/157488809787169138","article-title":"Stem cells as vectors to deliver HSV\/tk gene therapy for malignant gliomas","volume":"4","author":"Rath","year":"2009","journal-title":"Current Stem Cell Res. Therapy"},{"key":"10.1016\/j.actbio.2018.09.015_b0040","doi-asserted-by":"crossref","first-page":"372","DOI":"10.1038\/sj.cgt.7700448","article-title":"TRAIL enhances thymidine kinase\/ganciclovir gene therapy of neuroblastoma cells","volume":"9","author":"Beltinger","year":"2002","journal-title":"Cancer Gene Therapy"},{"key":"10.1016\/j.actbio.2018.09.015_b0045","first-page":"1162","article-title":"Induction and intracellular regulation of tumor necrosis factor-related apoptosis-inducing ligand (TRAIL) mediated apotosis in human malignant glioma cells","volume":"61","author":"Hao","year":"2001","journal-title":"Cancer Res."},{"key":"10.1016\/j.actbio.2018.09.015_b0050","doi-asserted-by":"crossref","first-page":"5789","DOI":"10.1038\/sj.onc.1204810","article-title":"Analysis of FasL and TRAIL induced apoptosis pathways in glioma cells","volume":"20","author":"Knight","year":"2001","journal-title":"Oncogene"},{"key":"10.1016\/j.actbio.2018.09.015_b0055","first-page":"1362","article-title":"Direct stimulation of apoptotic signaling by soluble Apo2l\/tumor necrosis factor-related apoptosis-inducing ligand leads to selective killing of glioma cells","volume":"7","author":"Pollack","year":"2001","journal-title":"Clin. Cancer Res: An Official J. Am. Assoc. Cancer Res."},{"key":"10.1016\/j.actbio.2018.09.015_b0060","doi-asserted-by":"crossref","first-page":"34","DOI":"10.2174\/157488709787047530","article-title":"TRAIL agonists on clinical trials for cancer therapy: the promises and the challenges","volume":"4","author":"Bellail","year":"2009","journal-title":"Rev. Recent Clin. Trials"},{"key":"10.1016\/j.actbio.2018.09.015_b0065","doi-asserted-by":"crossref","first-page":"3538","DOI":"10.1016\/j.biomaterials.2011.01.054","article-title":"Improved biological half-life and anti-tumor activity of TNF-related apoptosis-inducing ligand (TRAIL) using PEG-exposed nanoparticles","volume":"32","author":"Lim","year":"2011","journal-title":"Biomaterials"},{"key":"10.1016\/j.actbio.2018.09.015_b0070","doi-asserted-by":"crossref","first-page":"337","DOI":"10.1016\/S1359-6101(03)00029-7","article-title":"Apo2L\/TRAIL: apoptosis signaling, biology, and potential for cancer therapy","volume":"14","author":"Almasan","year":"2003","journal-title":"Cytokine Growth Factor Rev."},{"key":"10.1016\/j.actbio.2018.09.015_b0075","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1002\/ana.20306","article-title":"Glioma therapy and real-time imaging of neural precursor cell migration and tumor regression","volume":"57","author":"Shah","year":"2005","journal-title":"Ann. Neurol."},{"key":"10.1016\/j.actbio.2018.09.015_b0080","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1038\/nn.3019","article-title":"Encapsulated therapeutic stem cells implanted in the tumor resection cavity induce cell death in gliomas","volume":"15","author":"Kauer","year":"2011","journal-title":"Nat. Neurosci."},{"key":"10.1016\/j.actbio.2018.09.015_b0085","doi-asserted-by":"crossref","first-page":"13","DOI":"10.2174\/1566523033347426","article-title":"Suicide gene therapy mediated by the Herpes Simplex virus thymidine kinase gene\/Ganciclovir system: fifteen years of application","volume":"3","author":"Fillat","year":"2003","journal-title":"Curr. Gene Therapy"},{"key":"10.1016\/j.actbio.2018.09.015_b0090","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1634\/stemcells.2004-0138","article-title":"Human fetal mesenchymal stem cells as vehicles for gene delivery","volume":"23","author":"Chan","year":"2005","journal-title":"Stem Cells"},{"key":"10.1016\/j.actbio.2018.09.015_b0095","doi-asserted-by":"crossref","first-page":"1322","DOI":"10.1002\/jgm.777","article-title":"Enhanced osteoinduction by mesenchymal stem cells transfected with a fiber-mutant adenoviral BMP2 gene","volume":"7","author":"Tsuda","year":"2005","journal-title":"J. Gene Med"},{"key":"10.1016\/j.actbio.2018.09.015_b0100","doi-asserted-by":"crossref","first-page":"515","DOI":"10.1016\/j.addr.2006.03.006","article-title":"Viral vectors for gene delivery in tissue engineering","volume":"58","author":"Zhang","year":"2006","journal-title":"Adv. Drug Delivery Rev."},{"key":"10.1016\/j.actbio.2018.09.015_b0105","doi-asserted-by":"crossref","first-page":"e105","DOI":"10.1016\/j.ddtec.2008.10.002","article-title":"Viral and non-viral gene delivery and its role in pluripotent stem cell engineering","volume":"5","author":"Kane","year":"2008","journal-title":"Drug Discovery Today Technol."},{"key":"10.1016\/j.actbio.2018.09.015_b0110","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1016\/j.jconrel.2007.09.004","article-title":"Non-viral is superior to viral gene delivery","volume":"123","author":"Li","year":"2007","journal-title":"J. Control. Release: Official J. Control. Release Soc."},{"key":"10.1016\/j.actbio.2018.09.015_b0115","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1016\/j.ddtec.2005.04.002","article-title":"Nonviral gene delivery systems: from simple transfection agents to artificial viruses","volume":"2","author":"Mastrobattista","year":"2005","journal-title":"Drug Discovery Today Technol."},{"key":"10.1016\/j.actbio.2018.09.015_b0120","doi-asserted-by":"crossref","first-page":"46","DOI":"10.2174\/156652311794520102","article-title":"Non-viral gene delivery to mesenchymal stem cells: methods, strategies and application in bone tissue engineering and regeneration","volume":"11","author":"Santos","year":"2011","journal-title":"Curr. Gene Therapy"},{"key":"10.1016\/j.actbio.2018.09.015_b0125","doi-asserted-by":"crossref","first-page":"410","DOI":"10.1016\/j.jconrel.2013.06.026","article-title":"Polylysine-modified polyethylenimine inducing tumor apoptosis as an efficient gene carrier","volume":"172","author":"Tian","year":"2013","journal-title":"J. Control. Release: Official J. Control. Release Soc."},{"key":"10.1016\/j.actbio.2018.09.015_b0130","doi-asserted-by":"crossref","first-page":"1593","DOI":"10.1093\/jnci\/djh299","article-title":"Mesenchymal stem cells: potential precursors for tumor stroma and targeted-delivery vehicles for anticancer agents","volume":"96","author":"Studeny","year":"2004","journal-title":"J. Natl. Cancer Inst."},{"key":"10.1016\/j.actbio.2018.09.015_b0135","doi-asserted-by":"crossref","first-page":"184","DOI":"10.1016\/j.actbio.2015.07.020","article-title":"miRNA oligonucleotide and sponge for miRNA-21 inhibition mediated by PEI-PLL in breast cancer therapy","volume":"25","author":"Gao","year":"2015","journal-title":"Acta Biomaterialia"},{"key":"10.1016\/j.actbio.2018.09.015_b0140","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1016\/j.actbio.2016.12.048","article-title":"Polylysine-modified polyethylenimine (PEI-PLL) mediated VEGF gene delivery protects dopaminergic neurons in cell culture and in rat models of Parkinson's Disease (PD)","volume":"54","author":"Sheikh","year":"2017","journal-title":"Acta Biomaterialia"},{"key":"10.1016\/j.actbio.2018.09.015_b0145","doi-asserted-by":"crossref","first-page":"1650","DOI":"10.1056\/NEJM198612253152606","article-title":"Tumors: wounds that do not heal. Similarities between tumor stroma generation and wound healing","volume":"315","author":"Dvorak","year":"1986","journal-title":"New England J. Med."},{"key":"10.1016\/j.actbio.2018.09.015_b0150","doi-asserted-by":"crossref","first-page":"597","DOI":"10.1586\/era.09.22","article-title":"Applications of neural and mesenchymal stem cells in the treatment of gliomas","volume":"9","author":"Kosztowski","year":"2009","journal-title":"Expert Rev. Anticancer Therapy"},{"key":"10.1016\/j.actbio.2018.09.015_b0155","doi-asserted-by":"crossref","first-page":"3908","DOI":"10.1073\/pnas.95.7.3908","article-title":"Engraftment and migration of human bone marrow stromal cells implanted in the brains of albino rats\u2013similarities to astrocyte grafts","volume":"95","author":"Azizi","year":"1998","journal-title":"Proc. Natl. Acad. Sci. U.S.A."},{"key":"10.1016\/j.actbio.2018.09.015_b0160","doi-asserted-by":"crossref","first-page":"747","DOI":"10.1097\/SLA.0b013e3181bd62d0","article-title":"Targeting tumor stroma using engineered mesenchymal stem cells reduces the growth of pancreatic carcinoma","volume":"250","author":"Zischek","year":"2009","journal-title":"Ann. Surgery"},{"key":"10.1016\/j.actbio.2018.09.015_b0165","doi-asserted-by":"crossref","first-page":"431","DOI":"10.1038\/cgt.2012.21","article-title":"Pharmacokinetic study of neural stem cell-based cell carrier for oncolytic virotherapy: targeted delivery of the therapeutic payload in an orthotopic brain tumor model","volume":"19","author":"Thaci","year":"2012","journal-title":"Cancer Gene Therapy"},{"key":"10.1016\/j.actbio.2018.09.015_b0170","doi-asserted-by":"crossref","first-page":"557","DOI":"10.1038\/nature06188","article-title":"Mesenchymal stem cells within tumour stroma promote breast cancer metastasis","volume":"449","author":"Karnoub","year":"2007","journal-title":"Nature"},{"key":"10.1016\/j.actbio.2018.09.015_b0175","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1016\/j.yexmp.2005.07.004","article-title":"Mesenchymal stem cells derived from bone marrow favor tumor cell growth in vivo","volume":"80","author":"Zhu","year":"2006","journal-title":"Exp. Mol. Pathol."},{"key":"10.1016\/j.actbio.2018.09.015_b0180","doi-asserted-by":"crossref","first-page":"1706","DOI":"10.1002\/stem.1355","article-title":"Therapeutic efficacy and fate of bimodal engineered stem cells in malignant brain tumors","volume":"31","author":"Martinez-Quintanilla","year":"2013","journal-title":"Stem Cells"},{"key":"10.1016\/j.actbio.2018.09.015_b0185","doi-asserted-by":"crossref","first-page":"415","DOI":"10.1158\/1078-0432.CCR-12-1568","article-title":"Complete regression of metastatic renal cell carcinoma by multiple injections of engineered mesenchymal stem cells expressing dodecameric TRAIL and HSV-TK","volume":"19","author":"Kim","year":"2013","journal-title":"Clin. Cancer Res: An Official J. Am. Assoc. Cancer Res."}],"container-title":["Acta Biomaterialia"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1742706118305324?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1742706118305324?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,28]],"date-time":"2025-10-28T17:11:03Z","timestamp":1761671463000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1742706118305324"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,10]]},"references-count":37,"alternative-id":["S1742706118305324"],"URL":"https:\/\/doi.org\/10.1016\/j.actbio.2018.09.015","relation":{},"ISSN":["1742-7061"],"issn-type":[{"value":"1742-7061","type":"print"}],"subject":[],"published":{"date-parts":[[2018,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Polylysine-modified polyethylenimine polymer can generate genetically engineered mesenchymal stem cells for combinational suicidal gene therapy in glioblastoma","name":"articletitle","label":"Article Title"},{"value":"Acta Biomaterialia","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.actbio.2018.09.015","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2018 Acta Materialia Inc. Published by Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}